NEW YORK (GenomeWeb News) – The External RNA Controls Consortium today said that eight testing sites have registered for the initial phase of the RNA control testing initiative.
 
The participants are: Affymetrix, Agilent, Applied Biosystems, GE Healthcare, Illumina, National Institute of Allergy and Infectious Diseases, Qiagen, and Roche Molecular Systems.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.